Public Health Implications of Avian Influenza Viruses

Avian Influenza

Volumn , Issue , 2009, Pages 453-484

  Cox, Nancy J ^a,b   Uyeki, Timothy M ^c  

^a Influenza Division   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

Antiviral medications; Baculovirus expressed HA; Global Influenza Surveillance Network (GISN); Influenza pandemics; Point of care tests; Prepandemic vaccines; Strain specific humoral immunity

Indexed keywords

EID: 77955424368     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780813818634.ch20     Document Type: Chapter

References (187)

1. Air, G.M., A.A. Ghate, and S.J. Stray. 1999. Influenza neuraminidase as target for antivirals. Advances in Virus Research 54:375-402.
2. Apisarnthanarak, A., S. Erb, I. Stephenson, J.M. Katz, M. Chittaganpitch, S. Sangkitporn, R. Kitphati, P. Thawatsupha, S. Waicharoen, U. Pinitchai, P. Apisarnthanarak, V.J. Fraser, and L.M. Mundy. 2005. Seroprevalence of anti-H5 antibody among Thai health care workers after exposure to avian influenza (H5N1) in a tertiary care center. Clinical Infectious Diseases 40(2):e16-e18.
3. Apisarnthanarak, A., R. Kitphati, K. Thongphubeth, P. Patoomanunt, P. Anthanont, W. Auwanit, P. Thawatsupha, M. Chittaganpitch, S. Saeng-Aroon, S. Waicharoen, P. Apisarnthanarak, G.A. Storch, L.M. Mundy, and V.J. Fraser. 2004. Atypical avian influenza (H5N1). Emerging Infectious Diseases 10(7):1321-1324.
4. Areechokchai, D., C. Jiraphongsa, Y. Laosiritaworn, W. Hanshaoworakul, and M. O'Reilly. 2006. Investigation of avian influenza (H5N1) outbreak in humans-Thailand, 2004. Morbidity and Mortality Weekly Report 55(Suppl. 1):3-6.
5. Banzhoff, A., E. Montomoli, A. Hilbert, F. Laghi-Pasini, P.L. Capecchi, C. Gentile, P. di Giovanni, T. Staniscia, A. Podda, P. Durando, L. Sticchi, and R. Gasparini. 2007. MF59-adjuvanted influenza vaccine is well tolerated and effective at low doses, offering a suitable vaccine for prepandemic vaccination programs. In:Abstracts for the Options for the Control of Influenza VI, Toronto, Canada, 201.
6. Beigel, J.H., J. Farrar, A.M. Han, F.G. Hayden, R. Hyer, J. de, S. Lochindarat, T.K. Nguyen, T.H. Nguyen, T.H. Tran, A. Nicoll, S. Touch, and K.Y. Yuen. 2005. Avian influenza A (H5N1) infection in humans. New England Journal of Medicine 353(13):1374-1385.
7. Beveridge, W.I. 1991. The chronicle of influenza epidemics. History and Philosophy of the Life Sciences 13(2):223-234.
8. Bhat, N., J.G. Wright, K.R. Broder, E.L. Murray, M.E. Greenberg, M.J. Glover, A.M. Likos, D.L. Posey, A. Klimov, S.E. Lindstrom, A. Balish, M.J. Medina, T.R. Wallis, J. Guarner, C.D. Paddock, W.J. Shieh, S.R. Zaki, J.J. Sejvar, D.K. Shay, S.A. Harper, N.J. Cox, K. Fukuda, and T.M. Uyeki. 2005. Influenza-associated deaths among children in the United States, 2003-2004. New England Journal of Medicine 353(24):2559-2567.
9. Brankston, G., L. Gitterman, Z. Hirji, C. Lemieux, and M. Gardam. 2007. Transmission of influenza A in human beings. Lancet Infectious Diseases 7(4):257-265.
10. Bresson, J.L., C. Perronne, O. Launay, C. Gerdil, M. Saville, J. Wood, K. Hoschler, and M.C. Zambon. 2006. Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine:phase I randomised trial. Lancet 367(9523):1657-1664.
11. Bridges, C.B., J. Katz, W.H. Seto, P.K. Chan, D.N. Tsang, W. Ho, K.H. Mak, W. Lim, J.S. Tam, M. Clarke, S.G. Williams, A.W. Mounts, J.S. Bresee, L. Conn, T. Rowe, J. Hu-Primmer, R.A. Abernathy, X. Lu, N.J. Cox, and K. Fukuda. 2000. Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong. Journal of Infectious Diseases 181:344-348.
12. Bridges, C.B., W. Lim, J. Hu-Primmer, L. Sims, K. Fukuda, K.H. Mak, T. Rowe, W.W. Thompson, L. Conn, X. Lu, N.J. Cox, and J.M. Katz. 2002. Risk of influenza A (H5N1) infection among poultry workers, Hong Kong, 1997-1998. Journal of Infectious Diseases 185(8):1005-1010.
13. Brydon, E.W., S.J. Morris, and C. Sweet. 2005. Role of apoptosis and cytokines in influenza virus morbidity. Federation of European Microbiological Societies Microbiological Reviews 29(4):837-850.
14. Buchy, P., S. Mardy, S. Vong, T. Toyoda, J.T. Aubin, M. Miller, S. Touch, L. Sovann, J.B. Dufourcq, B. Richner, P.V. Tu, N.T. Tien, W. Lim, J.S. Peiris, and W.S. Van der. 2007. Inflenza A/H5N1 virus infection in humans in Cambodia. Journal of Clinical Virology 39(3):164-168.
15. Butt, K.M., G.J. Smith, H. Chen, L.J. Zhang, Y.H. Leung, K.M. Xu, W. Lim, R.G. Webster, K.Y. Yuen, J.S. Peiris, and Y. Guan. 2005. Human infection with an avian H9N2 influenza A virus in Hong Kong in 2003. Journal of Clinical Microbiology 43(11):5760-5767.
16. Call, S.A., M.A. Vollenweider, C.A. Hornung, D.L. Simel, and W.P. McKinney. 2005. Does this patient have influenza? Journal of the American Medical Association 293(8):987-997.
17. Centers for Disease Control and Prevention. 2004. Update:Influenza activity-United States and worldwide, 2003-2004 season, and composition of the 2004-05 influenza vaccine. Morbidity and Mortality Weekly Report 53:547-552.
18. Centers for Disease Control and Prevention. 2004. Update:Influenza activity-United States, 2003-2004 Season. Morbidity and Mortality Weekly Report 53:284-287.
19. Centers for Disease Control and Prevention. Interim guidance for protection of persons involved in U.S. avian influenza outbreak disease control and eradication activities. Available at http://www.cdc.gov/flu/avian/professional/protect-guid.htm. Centers for Disease Control and Prevention:Atlanta, GA.
20. Chan, P.K. 2002. Outbreak of avian influenza A (H5N1) virus infection in Hong Kong in 1997. Clinical Infectious Diseases 34(Suppl. 2):S58-S64.
21. Chen, W., P.A. Calvo, D. Malide, J. Gibbs, U. Schubert, I. Bacik, S. Basta, R. O'Neill, J. Schickli, P. Palese, P. Henklein, J.R. Bennink, and J.W. Yewdell. 2001. A novel influenza A virus mitochondrial protein that induces cell death. Nature Medicine 7(12):1306-1312.
22. Choi, Y.K., T.D. Nguyen, H. Ozaki, R.J. Webby, P. Puthavathana, C. Buranathal, A. Chaisingh, P. Auewarakul, N.T. Hanh, S.K. Ma, P.Y. Hui, Y. Guan, J.S. Peiris, and R.G. Webster. 2005. Studies of H5N1 influenza virus infection of pigs by using viruses isolated in Vietnam and Thailand in 2004. Journal of Virology 79(16):10821-10825.
23. Chotpitayasunondh, T., K. Ungchusak, W. Hanshaoworakul, S. Chunsuthiwat, P. Sawanpanyalert, R. Kijphati, S. Lochindarat, P. Srisan, P. Suwan, Y. Osotthanakorn, T. Anantasetagoon, S. Kanjanawasri, S. Tanupattarachai, J. Weerakul, R. Chaiwirattana, M. Maneerattanaporn, R. Poolsavathitikool, K. Chokephaibulkit, A. Apisarnthanarak, and S.F. Dowell. 2005. Human disease from influenza A (H5N1), Thailand, 2004. Emerging Infectious Diseases 11(2):201-209.
24. Chutinimitkul, S., P. Bhattarakosol, S. Srisuratanon, A. Eiamudomkan, K. Kongsomboon, S. Damrongwatanapokin, A. Chaisingh, K. Suwannakarn, T. Chieochansin, A. Theamboonlers, and Y. Poovorawan. 2006. H5N1 influenza A virus and infected human plasma. Emerging Infectious Diseases 12(6):1041-1043.
25. Cox, N.J., G. Neumann, R.O. Donis, and Y. Kawaoka. 2005. Orthomyxoviruses:influenza. In:B. Mahy and V. Meulen (eds.). Topley and Wilson's Microbiology and Microbial Infections, 10th ed. Hodder Arnold:London, pp. 634-688.
26. Cox, N.J. and K. Subbarao. 1999. Influenza. Lancet 354(9186):1277-1282.
27. Dawson, E.D., C.L. Moore, D.M. Dankbar, M. Mehlmann, M.B. Townsend, J.A. Smagala, C.B. Smith, N.J. Cox, R.D. Kuchta, and K.L. Rowlen. 2007. Identification of A/H5N1 influenza viruses using a single gene diagnostic microarray. Analytical Chemistry 79(1):378-384.
28. de Jong, M.D., V.C. Bach, T.Q. Phan, M.H. Vo, T.T. Tran, B.H. Nguyen, M. Beld, T.P. Le, H.K. Truong, V.V. Nguyen, T.H. Tran, Q.H. Do, and J. Farrar. 2005. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. New England Journal of Medicine 352(7):686-691.
29. de, J., T.T. Tran, H.K. Truong, M.H. Vo, G.J. Smith, V.C. Nguyen, V.C. Bach, T.Q. Phan, Q. H. Do, Y. Guan, J.S. Peiris, T.H. Tran, and J. Farrar. 2005. Oseltamivir resistance during treatment of influenza A (H5N1) infection. New England Journal of Medicine 353(25):2667-2672.
30. Dejpichai, R., Y. Laosititaworn, P. Phuthavathana, T. Uyeki, M. O'Reilly, N. Yampikulsakul, S. Phurahong, P. Poorak, J. Prasertsopon, R. Kularb, K. Nateerom, N. Sawanpanyalert, and C. Jiraphongsa. 2007. Seroprevalence of antibodies to avian influenza A (H5N1) virus among residents of villages with confirmed human H5N1 cases, Thailand, 2004-05. In:Abstracts for the Options for the Control of Influenza VI, Toronto, Canada, p. 18.
31. DeLay, P.D., H.L. Casey, and H.S. Tubiash. 1967. Comparative study of fowl plague virus and a virus isolated from man. Public Health Reports 82(7):615-620.
32. Department of Health Press Release. 2007. The Government of the Hong Kong Special Administrative Region, March 20, 2007. Press Release.
33. Department of the Interior. 2007. Employee health and safety guidance for avian influenza surveillance and control in wild birds. Available at http://medical.smis.doi.gov/avian%20safety% 20and%20health.pdf. Department of the Interior:Washington, D.C.
34. Dinh, P.N., H.T. Long, N.T. Tien, N.T. Hien, T.Q. Mai le, l.H. Phong, l. Tuan, V, T.H. Van, N.B. Nguyen, T.P. Van, and N.T. Phuong. 2006. Risk factors for human infection with avian influenza A H5N1, Vietnam, 2004. Emerging Infectious Diseases 12(12):1841-1847.
35. Du Ry van Beest Holle, A. Meijer, M. Koopmans, and C.M. de Jager. 2005. Human-to-human transmission of avian influenza A/H7N7, The Netherlands, 2003. European Surveillance 10(12):264-268.
36. Edwards, L.E., P. Terebuh, A. Adija, T. Rowe, J. Kleene, J. Hu-Primmer, S. Jenkins, K. Fukuda, N. Cox, J. Katz, and C. Bridges. 2004. Serological diagnosis of human infection with avian influenza (H7N2) virus. In:Abstracts of the International Conference on Emerging Infectious Diseases, Atlanta, GA, Abstract 60.
37. Ellis, J.S., J.W. Smith, S. Braham, M. Lock, K. Barlow, and M.C. Zambon. 2007. Design and validation of an H5 TaqMan real-time one-step reverse transcription-PCR and confirmatory assays for diagnosis and verification of influenza A virus H5 infections in humans. Journal of Clinical Microbiology 45(5):1535-1543.
38. Fedorko, D.P., N.A. Nelson, J.M. McAuliffe, and K. Subbarao. 2006. Performance of rapid tests for detection of avian influenza A virus types H5N1 and H9N2. Journal of Clinical Microbiology 44(4):1596-1597.
39. Fiore, A.E., D.K. Shay, P. Haber, J.K. Iskander, T.M. Uyeki, G. Mootrey, J.S. Bresee, and N.J. Cox. 2007. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. Morbidity and Morality Weekly Report Recommended Report 56(RR-6):1-54.
40. Fouchier, R.A., P.M. Schneeberger, F.W. Rozendaal, J.M. Broekman, S.A. Kemink, V. MunSwayne and R.D. Slemons (eds.). Proceedings of the Fourth International Symposium on Avian Influenza, May 29-31, 1997, Athens, Georgia. Symposium on Avian Influenza, US Animal Health Association:Richmond, VA, pp. 14-17.
41. Fox, J.P., C.E. Hall, M.K. Cooney, and H.M. Foy. 1982. Influenzavirus infections in Seattle families, 1975-1979. I. Study design, methods and the occurrence of infections by time and age. American Journal of Epidemiology 116(2):212-227.
42. Frank, A.L., L.H. Taber, W.P. Glezen, E.A. Geyer, S. McIlwain, and A. Paredes. 1983. Influenza B virus infections in the community and the family. The epidemics of 1976-1977 and 1979-1980 in Houston, Texas. American Journal of Epidemiology 118(3):313-325.
43. Frank, A.L., L.H. Taber, C.R. Wells, J.M. Wells, W.P. Glezen, and A. Paredes. 1981. Patterns of shedding of myxoviruses and paramyxoviruses in children. Journal of Infectious Diseases 144(5):433-441.
44. Gerhard, W. 2001. The role of the antibody response in influenza virus infection. Current Topics in Microbiology and Immunology 260:171-190.
45. Gill, J.S., R. Webby, M.J. Gilchrist, and G.C. Gray. 2006. Avian influenza among waterfowl hunters and wildlife professionals. Emerging Infectious Diseases 12(8):1284-1286.
46. Gilsdorf, A., N. Boxall, V. Gasimov, I. Agayev, F. Mammadzade, P. Ursu, E. Gasimov, C. Brown, S. Mardel, D. Jankovic, G. Pimentel, I.A. Ayoub, E.M. Elassal, C. Salvi, D. Legros, S.C. Pessoa da, A. Hay, R. Andraghetti, G. Rodier, and B. Ganter. 2006. Two clusters of human infection with influenza A/H5N1 virus in the Republic of Azerbaijan, February-March 2006. European Surveillance 11(5):122-126.
47. Glezen, W.P. and R.B. Couch. 1978. Interpandemic influenza in the Houston area, 1974-76. New England Journal of Medicine 298(11):587-592.
48. Glezen, W.P., R.B. Couch, L.H. Taber, A. Paredes, J.E. Allison, A.L. Frank, and C. Aldridge. 1980. Epidemiologic observations of influenza B virus infections in Houston, Texas, 1976-1977. American Journal of Epidemiology 111(1):13-22.
49. Guo, Y., J. Li, and X. Cheng. 1999. Discovery of men infected by avian influenza A (H9N2) virus. Chinese Journal of Experimental and Clinical Virology 13(2):105-108.
50. Guo, Y., M. Xie, J. Wang, J. Dang, Y. Guo, Y. Zhang, and K. Wu. 2000. A strain of influenza A H9N2 virus repeatedly isolated from human population in China. Chinese Journal of Experimental and Clinical Virology 14:209-212.
51. Gursel, M., D. Verthelyi, I. Gursel, K.J. Ishii, and D.M. Klinman. 2002. Differential and competitive activation of human immune cells by distinct classes of CpG oligodeoxynucleotide. Journal Leukocyte Biology 71(5):813-820.
52. Hall, W.J., R.G. Douglas, Jr., R.W. Hyde, F.K. Roth, A.S. Cross, and D.M. Speers. 1976. Pulmonary mechanics after uncomplicated influenza A infection. American Review of Respiratory Diseases 113(2):141-148.
53. Hayden, F.G., R. Fritz, M.C. Lobo, W. Alvord, W. Strober, and S.E. Straus. 1998. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. Journal of Clinical Investigation 101(3):643-649.
54. Hehme, N., H. Engelmann, W. Kunzel, E. Neumeier, and R. Sanger. 2002. Pandemic preparedness:lessons learnt from H2N2 and H9N2 candidate vaccines. Medical Microbiology and Immunology 191(3-4):203-208.
55. Hehme, N.W. 2007. GSK's pandemic vaccine development from 1st to 2nd generation candidate vaccines. World Health Organization:Geneva.
56. Hers, J.F., and J. Mulder. 1961. Broad aspects of the pathology and pathogenesis of human influenza. American Review of Respiratory Disease 83(2)Pt 2:84-97.
57. Hien, T.T., N.T. Liem, N.T. Dung, L.T. San, P.P. Mai, N.N. Chau, P.T. Suu, V.C. Dong, L.T. Mai, N.T. Thi, D.B. Khoa, L.P. Phat, N.T. Truong, H.T. Long, L.T. Giang, N.D. Tho, L.H. Nga, N.T. Tien, L.H. San, L.V. Tuan, C. Dolecek, T.T. Thanh, M. De Jong, C. Schultsz, P. Cheng, W. Lim, P. Horby, J. Farrar, and K.F.T.U. WHO International Avian Influenza Investigative team 2004. Avian influenza A (H5N1) in 10 patients in Vietnam. New England Journal of Medicine 350:1179-1188.
58. Hilleman, M.R. 2002. Realities and enigmas of human viral influenza:pathogenesis, epidemiology and control. Vaccine 20(25-26):3068-3087.
59. Horimoto, T., and Y. Kawaoka. 2005. Influenza:lessons from past pandemics, warnings from current incidents. Nature Reviews Microbiology 3(8):591-600.
60. Horner, G.J., and F.D. Gray, Jr. 1973. Effect of uncomplicated, presumptive influenza on the diffusing capacity of the lung. American Review of Respiratory Disease 108(4):866-869.
61. Imai, M., A. Ninomiya, H. Minekawa, T. Notomi, T. Ishizaki, M. Tashiro, and T. Odagiri. 2006. Development of H5-RT-LAMP (loop-mediated isothermal amplification) system for rapid diagnosis of H5 avian influenza virus infection. Vaccine 24(44-46):6679-6682.
62. Izurieta, H.S., W.W. Thompson, P. Kramarz, D.K. Shay, R.L. Davis, F. DeStefano, S. Black, H. Shinefield, and K. Fukuda. 2000. Influenza and the rates of hospitalization for respiratory disease among infants and young children. New England Journal of Medicine 342(4):232-239.
63. Johansson, B.E., P.M. Price, and E.D. Kilbourne. 1995. Immunogenicity of influenza A virus N2 neuraminidase produced in insect larvae by baculovirus recombinants. Vaccine 13(9):841-845.
64. Kandun, I.N., E.R. Sedyaningsih, and T.M. Uyeki. 2007. Human H5N1 influenza-Dr. Kandun and colleagues reply. New England Journal of Medicine 356(13):1376-1377.
65. Kandun, I.N., H. Wibisono, E.R. Sedyaningsih, Yusharmen, W. Hadisoedarsuno, W. Purba, H. Santoso, C. Septiawati, E. Tresnaningsih, B. Heriyanto, D. Yuwono, S. Harun, S. Soeroso, S. Giriputra, P.J. Blair, A. Jeremijenko, H. Kosasih, S.D. Putnam, G. Samaan, M. Silitonga, K.H. Chan, L.L. Poon, W. Lim, A. Klimov, S. Lindstrom, Y. Guan, R. Donis, J. Katz, N. Cox, M. Peiris, and T.M. Uyeki. 2006. Three Indonesian clusters of H5N1 virus infection in 2005. New England Journal of Medicine 355(21):2186-2194.
66. Karron, R. 2007. Phase 1 evaluation of live attenuated H9N2 and H5N1 ca reassortant vaccines in healthy adults. World Health Organization:Geneva.
67. Katz, J.M., A.I. Klimov, S.E. Lindstrom, and N.J. Cox. 2006. Influenza viruses. In:B. Detrick, R.G. Hamilton, and J.D. Folds (eds.). Manual of Molecular and Clinical Laboratory Immunology, 7th ed. ASM Press:Washington, D.C., pp. 691-699.
68. Katz, J.M., and R.G. Webster. 1992. Amino acid sequence identity between the HA1 of influenza A (H3N2) viruses grown in mammalian and primary chick kidney cells. Journal of General Virology 73(Pt 5):1159-1165.
69. Keawcharoen, J., K. Oraveerakul, T. Kuiken, R.A. Fouchier, A. Amonsin, S. Payungporn, S. Noppornpanth, S. Wattanodorn, A. Theambooniers, R. Tantilertcharoen, R. Pattanarangsan, N. Arya, P. Ratanakorn, D.M. Osterhaus, and Y. Poovorawan. 2004. Avian influenza H5N1 in tigers and leopards. Emerging Infectious Diseases 10(12):2189-2191.
70. Kistner, O. 2007. Phase 1/2 clinical study with Baxters H5N1 vaccine. World Health Organization:Geneva.
71. Koopmans, M., B. Wilbrink, M. Conyn, G. Natrop, N.H. van der, H. Vennema, A. Meijer, S.J. van, R. Fouchier, A. Osterhaus, and A. Bosman. 2004. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet 363(9409):587-593.
72. Kuhne, M., O. Morgan, J. Ellis, P. Nair, T.G. Wreghitt, M.D. Curran, R.J. Manvell, B.Z. Londt, I.H. Brown, and M. Zambon. 2007. Human antibody response to avian influenza A (H7N3) virus during an outbreak in poultry in Norfolk, United Kingdom. In:Abstracts of the Options for the Control of Influenza VI, Toronto, Canada, p. 137.
73. Kuiken, T., G. Rimmelzwaan, R.D. van, A.G. van, M. Baars, R. Fouchier, and A. Osterhaus. 2004. Avian H5N1 influenza in cats. Science 306(5694):241.
74. Kurtz, J., R.J. Manvell, and J. Banks. 1996. Avian influenza virus isolated from a woman with conjunctivitis. Lancet 348(9031):901-902.
75. Lakey, D.L., J.J. Treanor, R.F. Betts, G.E. Smith, J. Thompson, E. Sannella, G. Reed, B.E. Wilkinson, and P.F. Wright. 1996. Recombinant baculovirus influenza A hemagglutinin vaccines are well tolerated and immunogenic in healthy adults. Journal of Infectious Diseases 174(4):838-841.
76. Lamb, R.A., and R.M. Krug. 2001. Orthomyxoviridae:the viruses and their replication. In:B.N. Fields, D.M. Knipe, and P.M. Howley (eds.). Fields Virology, 4th ed. Lippincott Williams & Wilkins:Philadelphia, PA, pp. 1487-1531.
77. Le, Q.M., M. Kiso, K. Someya, Y.T. Sakai, T.H. Nguyen, K.H. Nguyen, N.D. Pham, H.H. Ngyen, S. Yamada, Y. Muramoto, T. Horimoto, A. Takada, H. Goto, T. Suzuki, Y. Suzuki, and Y. Kawaoka. 2005. Avian flu:isolation of drugresistant H5N1 virus. Nature 437(7062):1108.
78. Leschnik, M., J. Weikel, K. Mostl, S. Revilla-Fernandez, E. Wodak, Z. Bago, E. Vanek, V. Benetka, M. Hess, and J.G. Thalhammer. 2007. Subclinical infection with avian influenza A (H5N1) virus in cats. Emerging Infectious Diseases 13(2):243-247.
79. Li, H.Y., K. Yu, H. Yang, X. Xin, J. Chen, P. Zhao, Y. Bi, and H. Chen. 2004. Isolation and characterization of H5N1 and H9N2 influenza viruses from pigs in China. Chinese Journal of Preventive Veterinary Medicine 26:1-6.
80. Li, J., S. Chen, and D.H. Evans. 2001. Typing and subtyping influenza virus using DNA microarrays and multiplex reverse transcriptase PCR. Journal of Clinical Microbiology. 39(2):696-704.
81. Li, S., C. Liu, A. Klimov, K. Subbarao, M.L. Perdue, D. Mo, Y. Ji, L. Woods, S. Hietala, and M. Bryant. 1999. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses. Journal of Infectious Diseases 179(5):1132-1138.
82. Liem, N.T., WHO Team, and W. Lim. 2005. Lack of H5N1 avian influenza transmission to hospital employees, Hanoi, 2004. Emerging Infectious Diseases 11(2):210-215.
83. Louria, D.B., H.L. Blumenfeld, J.T. Ellis, E.D. Kilbourne, and D.E. Rogers. 1959. Studies on influenza in the pandemic of 1957-1958. II. Pulmonary complications of influenza. Journal of Clinical Investigation 38(1 Part 2):213-265.
84. Mackay, I.M., K.E. Arden, and A. Nitsche. 2002. Real-time PCR in virology. Nucleic Acids Research 30(6):1292-1305.
85. Martin, C.M., C.M. Kunin, L.S. Gottlieb, M.W. Barnes, C. Liu, and M. Finland. 1959. Asian influenza A in Boston, 1957-1958. I. Observations in thirty-two influenza-associated fatal cases. Archives of Internal Medicine 103(4):515-531.
86. Matrosovich, M., N. Zhou, Y. Kawaoka, and R. Webster. 1999. The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties. Journal of Virology 73(2):1146-1155.
87. Matrosovich, M.N., T.Y. Matrosovich, T. Gray, N.A. Roberts, and H.D. Klenk. 2004. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proceedings of the National Academy of Sciences U S A 101(13):4620-4624.
88. Moldoveanu, Z., L. Love-Homan, W.Q. Huang, and A.M. Krieg. 1998. CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus. Vaccine 16(11-12):1216-1224.
89. Monto, A.S., J.S. Koopman, and I.M. Longini, Jr. 1985. Tecumseh study of illness. XIII. Influenza infection and disease, 1976-1981. American Journal of Epidemiology 121(6):811-822.
90. Morens, D.M., and A.S. Fauci. 2007. The 1918 influenza pandemic:insights for the 21st century. Journal of Infectious Diseases 195(7):1018-1028.
91. Mounts, A.W., H. Kwong, H.S. Izurieta, Y. Ho, T. Au, M. Lee, B.C. Buxton, S.W. Williams, K. H. Mak, J.M. Katz, W.W. Thompson, N.J. Cox, and K. Fukuda. 1999. Case-control study of risk factors for avian influenza A (H5N1) disease, Hong Kong, 1997. Journal of Infectious Diseases 180(2):505-508.
92. Munster, V.J., W.E. de, R.D. van, W.E. Beyer, G.F. Rimmelzwaan, A.D. Osterhaus, T. Kuiken, and R.A. Fouchier. 2007. The molecular basis of the pathogenicity of the Dutch highly pathogenic human influenza A H7N7 viruses. Journal of Infectious Diseases 196(2):258-265.
93. Myers, K.P., S.F. Setterquist, A.W. Capuano, and G.C. Gray. 2007. Infection due to 3 avian influenza subtypes in United States veterinarians. Clinical Infectious Diseases 45(1):4-9.
94. Nair, P., H. Mahgoub, O. Morgan, S. Ibbotson, C. Sellwood, and J.S. Nguyen Van Tam. 2007. Public health response to an outbreak of low pathogenicity H7N3 avian influenza in UK, including an associated case of human conjunctivitis. In:Abstracts of the Options for the Control of Influenza VI, Toronto, Canada, p. 130.
95. Neumann, G., T. Watanabe, H. Ito, S. Watanabe, H. Goto, P. Gao, M. Hughes, D.R. Perez, R. Donis, E. Hoffmann, G. Hobom, and Y. Kawaoka. 1999. Generation of influenza A viruses entirely from cloned cDNAs. Proceedings of the National Academy of Sciences USA 96(16):9345-9350.
96. Neuzil, K.M., B.G. Mellen, P.F. Wright, E.F. Mitchel, and M.R. Griffin. 2000. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. New England Journal of Medicine 342(4):225-231.
97. Newman, R.W., R. Jennings, D.L. Major, J.S. Robertson, R. Jenkins, C.W. Potter, I. Burnett, L. Jewes, M. Anders, D. Jackson, and J.S. Oxford. 1993. Immune response of human volunteers and animals to vaccination with egg-grown influenza A (H1N1) virus is influenced by three amino acid substitutions in the haemagglutinin molecule. Vaccine 11(4):400-406.
98. Nguyen-Van-Tam, J.S. 2007. Oral presentation, Options for the Control of Influenza VI, Toronto, Canada.
99. Nguyen-Van-Tam, J.S., and A.W. Hampson. 2003. The epidemiology and clinical impact of pandemic influenza. Vaccine 21(16):1762-1768.
100. Nguyen-Van-Tam, J.S., P. Nair, P. Acheson, A. Baker, M. Barker, S. Bracebridge, J. Croft, J. Ellis, R. Gelletlie, N. Gent, S. Ibbotson, C. Joseph, H. Mahgoub, P. Monk, T.W. Reghitt, T. Sundkvist, C. Sellwood, J. Simpson, J. Smith, J.M. Watson, M. Zambon, and N. Lightfoot. 2006. Outbreak of low pathogenicity H7N3 avian influenza in UK, including associated case of human conjunctivitis. European Surveillance 11(5):E060504.
101. Nicholls, J.M., M.C. Chan, W.Y. Chan, H.K. Wong, C.Y. Cheung, D.L. Kwong, M.P. Wong, W.H. Chui, L.L. Poon, S.W. Tsao, Y. Guan, and J.S. Peiris. 2007. Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nature Medicine 13(2):147-149.
102. Nicholson, K.G., A.E. Colegate, A. Podda, I. Stephenson, J. Wood, E. Ypma, and M.C. Zambon. 2007. Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/duck/Singapore/97 (H5N3) vaccine:a randomised trial of two potential vaccines against H5N1 influenza. Lancet 357(9272):1937-1943.
103. O'Brien, M.A., T.M. Uyeki, D.K. Shay, W.W. Thompson, K. Kleinman, A. McAdam, X.J. Yu, R. Platt, and T.A. Lieu. 2004. Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. Pediatrics 113(3 Pt 1):585-593.
104. Oner, A.F., A. Bay, S. Arslan, H. Akdeniz, H.A. Sahin, Y. Cesur, S. Epcacan, N. Yilmaz, I. Deger, B. Kizilyildiz, H. Karsen, and M. Ceyhan. 2006. Avian influenza A (H5N1) infection in eastern Turkey in 2006. New England Journal of Medicine 355(21):2179-2185.
105. Ortiz, E.J., T.J. Kochel, A.W. Capuano, S.F. Setterquist, and G.C. Gray. 2007. Avian influenza and poultry workers, Peru, 2006. Influenza and Other Respiratory Diseases 1:65-69.
106. Ortiz, J.R., M.A. Katz, M.N. Mahmoud, S. Ahmed, S.I. Bawa, E.C. Farnon, M.B. Sarki, A. Nasidi, M.S. Ado, A.H. Yahaya, T.M. Joannia, R.S. Akpan, J. Vertefeuille, J. Achenbach, R.F. Breiman, J.M. Katz, T.M. Uyeki, and S.S. Wali. 2007. Lack of evidence for avian-to-human transmission of avian influenza A (H5N1) among poultry workers, Kano Nigeria, 2006. Journal of Infectious Diseases 196:1685-1691.
107. OSHA. 2004. Avian Influenza. Protecting Workers at Risk. Available at http://www. osha.gov/dts/shib/shib121304.html. Occupational Health and Safety Administration:Washington, D.C.
108. Palese, P. 2006. Making better influenza virus vaccines? Emerging Infectious Diseases 12(1):61-65.
109. Peiris, J.S., et al. 2007. Avian influenza virus (H5N1):a threat to human health. Clinical Microbiology Reviews 20(2):243-267.
110. Peiris, J.S., W.C. Yu, C.W. Leung, C.Y. Cheung, W.F. Ng, J.M. Nicholls, T.K. Ng, K.H. Chan, S.T. Lai, W.L. Lim, K.Y. Yuen, and Y. Guan. 2004. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 363(9409):617-619.
111. Peiris, M., K.Y. Yuen, C.W. Leung, K.H. Chan, P.L. Ip, R.W. Lai, W.K. Orr, and K.F. Shortridge. 1999. Human infection with influenza H9N2. Lancet 354(9182):916-917.
112. Poehling, K.A., K.M. Edwards, G.A. Weinberg, P. Szilagyi, M.A. Staat, M.K. Iwane, C.B. Bridges, C.G. Grijalva, Y. Zhu, D.I. Bernstein, G. Herrera, D. Erdman, C.B. Hall, R. Seither, and M.R. Griffin. 2006. The underrecognized burden of influenza in young children. New England Journal of Medicine 355(1):31-40.
113. Poon, L.L., C.S. Leung, K.H. Chan, J.H. Lee, K.Y. Yuen, Y. Guan, and J.S. Peiris. 2005. Detection of human influenza A viruses by loopmediated isothermal amplification. Journal of Clinical Microbiology 43(1):427-430.
114. Powers, D.C., G.E. Smith, E.L. Anderson, D.J. Kennedy, C.S. Hackett, B.E. Wilkinson, F. Volvovitz, R.B. Belshe, and J.J. Treanor. 1995. Influenza A virus vaccines containing purified recombinant H3 hemagglutinin are well tolerated and induce protective immune responses in healthy adults. Journal of Infectious Diseases 171(6):1595-1599.
115. Puzelli, S., T.L. Di, C. Fabiani, L. Campitelli, M.A. De Marco, I. Capua, J.F. Aguilera, M. Zambon, and I. Donatelli. 2005. Serological analysis of serum samples from humans exposed to avian H7 influenza viruses in Italy between 1999 and 2003. Journal of Infectious Diseases 192(8):1318-1322.
116. Reid, A.H., T.G. Fanning, T.A. Janczewski, R.M. Lourens, and J.K. Taubenberger. 2004. Novel origin of the 1918 pandemic influenza virus nucleoprotein gene. Journal of Virology 78(22):12462-12470.
117. Reid, A.H., J.K. Taubenberger, and T.G. Fanning. 2004. Evidence of an absence:the genetic origins of the 1918 pandemic influenza virus. Nature Reviews Microbiology 2(11):909-914.
118. Rimmelzwaan, G.F., R.D. van, M. Baars, T.M. Bestebroer, A.G. van, R.A. Fouchier, A.D. Osterhaus, and T. Kuiken. 2006. Influenza A virus (H5N1) infection in cats causes systemic disease with potential novel routes of virus spread within and between hosts. American Journal of Pathology 168(1):176-183.
119. Robertson, S.I. 2006. Avian influenza H5N1 in viverrids:implications for wildlife health and conservation. Proceedings Biological Sciences 273(1595):1729-1732.
120. Rocha, E., N.J. Cox, R.A. Black, M.W. Harmon, C.J. Harrison, and A.P. Kendal. 1991. Antigenic and genetic variation in influenza A (H1N1) virus isolates recovered from a persistently infected immunodeficient child. Journal of Virology 65(5):2340-2350.
121. Rogers, G.N., and J.C. Paulson. 1983. Receptor determinants of human and animal influenza virus isolates:differences in receptor specificity of the H3 hemagglutinin based on species of origin. Virology 127(2):361-373.
122. Rowe, T., R.A. Abernathy, J. Hu-Primmer, W.W. Thompson, X. Lu, W. Lim, K. Fukuda, N.J. Cox, and J.M. Katz. 1999. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. Journal of Clinical Microbiology 37(4):937-943.
123. Rudenko, L., and A. Katlinsky. 2007. Evaluation of Russian Live Attenuated Vaccine H5N2 in Clinical Trials. World Health Organization:Geneva.
124. Schultsz, C., V.C. Dong, N.V. Chau, N.T. Le, W. Lim, T.T. Thanh, C. Dolecek, J. de, T.T. Hien, and J. Farrar. 2005. Avian influenza H5N1 and healthcare workers. Emerging Infectious Diseases 11(7):1158-1159.
125. Schunemann, H.J., S.R. Hill, M. Kakad, R. Bellamy, T.M. Uyeki, F.G. Hayden, Y. Yazdanpanah, J. Beigel, T. Chotpitayasunondh, M.C. Del, J. Farrar, T.H. Tran, B. Ozbay, N. Sugaya, K. Fukuda, N. Shindo, L. Stockman, G.E. Vist, A. Croisier, A. Nagjdaliyev, C. Roth, G. Thomson, H. Zucker, and A.D. Oxman. 2007. WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus. Lancet Infectious Diseases 7(1):21-31.
126. Sedyaningsih, E.R., S. Isfandari, V. Setiawaty, L. Rifati, S. Harun, W. Purba, S. Imari, S. Giriputra, P.J. Blair, S.D. Putnam, T.M. Uyeki, and T. Soendoro. 2007. Epidemiology of cases of H5N1 virus infection in Indonesia, July 2005-June 2006. Journal of Infectious Diseases 196(4):522-527.
127. Shinya, K., M. Ebina, S. Yamada, M. Ono, N. Kasai, and Y. Kawaoka. 2006. Avian flu:influenza virus receptors in the human airway. Nature 440(7083):435-436.
128. Shortridge, K.F. 1992. Pandemic influenza:a zoonosis? Seminar on Respiratory Infections 7(1):11-25.
129. Shu, Y., H. Yu, and D. Li. 2006. Lethal avian influenza A (H5N1) infection in a pregnant woman in Anhui Province, China. New England Journal of Medicine 354(13):1421-1422.
130. Simmons, C.P., N.L. Bernasconi, A.L. Suguitan, K. Mills, J.M. Ward, N.V. Chau, T.T. Hien, F. Sallusto, d.Q. Ha, J. Farrar, A. Lanzavecchia, and K. Subbarao. 2007. Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza. Public Library of Science Medicine 4(5):e178.
131. Simonsen, L., K. Fukuda, L.B. Schonberger, and N.J. Cox. 2000. The impact of influenza epidemics on hospitalizations. Journal of Infectious Diseases 181(3):831-837.
132. Skowronski, D.M., S.A. Tweed, M. Petric, T. Booth, Y. Li, and T. Tam. 2006. Human illness and isolation of low-pathogenicity avian influenza virus of the H7N3 subtype in British Columbia, Canada. Journal of Infectious Diseases 193(6):899-900.
133. Songserm, T., A. Amonsin, R. Jam-on, N. Sae-Heng, N. Pariyothorn, S. Payungporn, A. Theamboonlers, S. Chutinimitkul, R. Thanawongnuwech, and Y. Poovorawan. 2006. Fatal avian influenza A H5N1 in a dog. Emerging Infectious Diseases 12(11):1744-1747.
134. Songserm, T., A. Amonsin, R. Jam-on, N. Sae-Heng, N. Meemak, N. Pariyothorn, S. Payungporn, A. Theamboonlers, and Y. Poovorawan. 2006. Avian influenza H5N1 in naturally infected domestic cat. Emerging Infectious Diseases 12(4):681-683.
135. Stephenson, I., R. Bugarini, K.G. Nicholson, A. Podda, J.M. Wood, M.C. Zambon, and J.M. Katz. 2005. Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/duck/Singapore/97 (H5N3) vaccine:a potential priming strategy. Journal of Infectious Diseases 191(8):1210-1215.
136. Stephenson, I., K.G. Nicholson, A. Colegate, A. Podda, J. Wood, E. Ypma, and M. Zambon. 2003. Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A/duck/Singapore/97 vaccine in a primed human population. Vaccine 21(15):1687-1693.
137. Stephenson, I., K.G. Nicholson, R. Gluck, R. Mischler, R.W. Newman, A.M. Palache, N.Q. Verlander, F. Warburton, J.M. Wood, and M.C. Zambon. 2003. Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults:phase I randomised trial. Lancet 362(9400):1959-1966.
138. Subbarao, K., H. Chen, D. Swayne, L. Mingay, E. Fodor, G. Brownlee, X. Xu, X. Lu, J. Katz, N. Cox, and Y. Matsuoka. 2003. Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmidbased reverse genetics. Virology 305(1):192-200.
139. Taubenberger, J.K. 2007. Discovery and characterization of the 1918 pandemic influenza virus in historical context. Antiviral Therapy 12:581-591.
140. Taubenberger, J.K., A.H. Reid, R.M. Lourens, R. Wang, G. Jin, and T.G. Fanning. 2005. Characterization of the 1918 influenza virus polymerase genes. Nature 437(7060):889-893.
141. Thomas, P.G., R. Keating, D.J. Hulse-Post, and P.C. Doherty. 2006. Cell-mediated protection in influenza infection. Emerging Infectious Diseases 12(1):48-54.
142. Thompson, W.W., D.K. Shay, E. Weintraub, L. Brammer, C.B. Bridges, N.J. Cox, and K. Fukuda. 2004. Influenza-associated hospitalizations in the United States. Journal of the American Medical Association 292(11):1333-1340.
143. Thompson, W.W., D.K. Shay, E. Weintraub, L. Brammer, N. Cox, L.J. Anderson, and K. Fukuda. 2003. Mortality associated with influenza and respiratory syncytial virus in the United States. Journal of the American Medical Association 289(2):179-186.
144. To, K.F., P.K. Chan, K.F. Chan, W.K. Lee, W.Y. Lam, K.F. Wong, N.L. Tang, D.N. Tsang, R.Y. Sung, T.A. Buckley, J.S. Tam, and A.F. Cheng. 2001. Pathology of fatal human infection associated with avian influenza A H5N1 virus. Journal of Medical Virology 63(3):242-246.
145. Townsend, M.B., E.D. Dawson, M. Mehlmann, J.A. Smagala, D.M. Dankbar, C.L. Moore, C.B. Smith, N.J. Cox, R.D. Kuchta, and K.L. Rowlen. 2006. Experimental evaluation of the FluChip diagnostic microarray for influenza virus surveillance. Journal of Clinical Microbiology 44(8):2863-2871.
146. Treanor, J.J., R.F. Betts, G.E. Smith, E.L. Anderson, C.S. Hackett, B.E. Wilkinson, R.B. Belshe, and D.C. Powers. 1996. Evaluation of a recombinant hemagglutinin expressed in insect cells as an influenza vaccine in young and elderly adults. Journal of Infectious Diseases 173(6):1467-1470.
147. Treanor, J.J., J.D. Campbell, K.M. Zangwill, T. Rowe, and M. Wolff. 2006. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. New England Journal of Medicine 354(13):1343-1351.
148. Treanor, J.J., B.E. Wilkinson, F. Masseoud, J. Hu-Primmer, R. Battaglia, D. O'Brien, M. Wolff, G. Rabinovich, W. Blackwelder, and J.M. Katz. 2006. Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans. Vaccine 19(13-14):1732-1737.
149. Tweed, S.A., D.M. Skowronski, S.T. David, A. Larder, M. Petric, W. Lees, Y. Li, J. Katz, M. Krajden, R. Tellier, C. Halpert, M. Hirst, C. Astell, D. Lawrence, and A. Mak. 2004. Human illness from avian influenza H7N3, British Columbia. Emerging Infectious Diseases 10(12):2196-2199.
150. Uiprasertkul, M., P. Puthavathana, K. Sangsiriwut, P. Pooruk, K. Srisook, M. Peiris, J.M. Nicholls, K. Chokephaibulkit, N. Vanprapar, and P. Auewarakul. 2005. Influenza A H5N1 replication sites in humans. Emerging Infectious Diseases 11(7):1036-1041.
151. Ulmer, J.B. 2002. Influenza DNA vaccines. Vaccine 20 (Suppl. 2):S74-S76.
152. Ungchusak, K., P. Auewarakul, S.F. Dowell, R. Kitphati, W. Auwanit, P. Puthavathana, M. Uiprasertkul, K. Boonnak, C. Pittayawonganon, N.J. Cox, S.R. Zaki, P. Thawatsupha, M. Chittaganpitch, R. Khontong, J.M. Simmerman, and S. Chunsutthiwat. 2005. Probable person-toperson transmission of avian influenza A (H5N1). New England Journal of Medicine 352(4):333-340.
153. Uyeki, T.M. 2003. Influenza diagnosis and treatment in children:a review of studies on clinically useful tests and antiviral treatment for influenza. Pediatric Infectious Diseases Journal 22(2):164-177.
154. Uyeki, T.M., Y.H. Chong, J.M. Katz, W. Lim, Y.Y. Ho, S.S. Wang, T.H. Tsang, W.W. Au, S.C. Chan, T. Rowe, J. Hu-Primmer, J.C. Bell, W.W. Thompson, C.B. Bridges, N.J. Cox, K.H. Mak, and K. Fukuda. 2002. Lack of Evidence for Human-to-Human Transmission of Avian Influenza A (H9N2) Viruses in Hong Kong, China 1999. Emerging Infectious Diseases 8(2):154-159.
155. van Riel D., V.J. Munster, W.E. de, G.F. Rimmelzwaan, R.A. Fouchier, A.D. Osterhaus, and T. Kuiken. 2006. H5N1 virus attachment to lower respiratory tract. Science 312(5772):399.
156. Verthelyi, D., R.T. Kenney, R.A. Seder, A.A. Gam, B. Friedag, and D.M. Klinman. 2002. CpG oligodeoxynucleotides as vaccine adjuvants in primates. Journal of Immunology 168(4):1659-1663.
157. Vong, S., B. Coghlan, S. Mardy, D. Holl, H. Seng, S. Ly, M.J. Miller, P. Buchy, Y. Froehlich, J.B. Dufourcq, T. Uyeki, W. Lim, and T. Sok. 2006. Low frequence of poultry-to-human H5N1 virus transmission, Southern Cambodia, 2005. Emerging Infectious Diseases 12(10):1542-1547.
158. Wagner, R., M. Matrosovich, and H.D. Klenk. 2002. Functional balance between haemagglutinin and neuraminidase in influenza virus infections. Reviews in Medical Virology 12(3):159-166.
159. Wang, M., B. Di, D.H. Zhou, B.J. Zheng, H. Jing, Y.P. Lin, Y.F. Liu, X.W. Wu, P.Z. Qin, Y.L. Wang, L.Y. Jian, X.Z. Li, J.X. Xu, E.J. Lu, T.G. Li, and J. Xu. 2006. Food markets with live birds as source of avian influenza. Emerging Infectious Diseases 12(11):1773-1775.
160. Webby, R.J., D.R. Perez, J.S. Coleman, Y. Guan, J.H. Knight, E.A. Govorkova, L.R. Clain-Moss, J.S. Peiris, J.E. Rehg, E.I. Tuomanen, and R.G. Webster. 2004. Responsiveness to a pandemic alert:use of reverse genetics for rapid development of influenza vaccines. Lancet 363(9415):1099-1103.
161. Webster, R.G., J. Geraci, G. Petursson, and K. Skirnisson. 1981. Conjunctivitis in human beings caused by influenza A virus of seals. New England Journal of Medicine 304(15):911.
162. Webster, R.G., and E.A. Govorkova. 2006. H5N1 influenza-continuing evolution and spread. New England Journal of Medicine 355(21):2174-2177.
163. Webster, R.G., M. Peiris, H. Chen, and Y. Guan. 2006. H5N1 outbreaks and enzootic influenza. Emerging Infectious Diseases 12(1):3-8.
164. World Health Organization. 2007. Acute respiratory infections:influenza. Available at http://www.who.int/vaccine_research/diseases/ari/en/. World Health Organization:Geneva.
165. World Health Organization. 2007. Recommendations for influenza vaccines. Available at http://www.who.int/csr/disease/influenza/vaccinerecommendations/en/. World Health Organization:Geneva.
166. World Health Organization. 2006. WHO criteria for accepting positive results of H5N1 infection in humans from national reference laboratories. Available at http://www.who.int/entity/csr/disease/avian_influenza/whoacceptancecrite ria. pdf. World Health Organization:Geneva.
167. World Health Organization. 2005. World Health Organization global influenza preparedness plan. Available at http://www.who.int/entity/csr/resources/publications/influenza/GIP_2005_ 5Eweb.pdf. World Health Organization:Geneva.
168. World Health Organization. 2007. World Health Organization global influenza surveillance network. Available at http://www.who.int/csr/disease/influenza/surveillance/en/. World Health Organization:Geneva.
169. World Health Organization/WPRO. 2004. World Health Organization interim recommendations for the protection of persons involved in the mass slaughter of animals potentially infected with highly pathogenic avian influenza viruses. Available at http://www.who.int/entity/csr/disease/avian_influenza/guidelines/interim_recommendations/en/index.html. World Health Organization/Western Pacific Regional Office:Manila.
170. World Health Organization. 2006. Avian influenza-H5N1 infection found in a Stone Marten in Germany, March 9, 2006. Available at http://www.who.int/csr/don/2006_03_09a/en/. World Health Organization:Geneva.
171. World Health Organization. 2006. Avian influenza-situation in Indonesia-update 16. May 31, 2006. Available at http://www.who.int/csr/don/2006_05_31/en/. World Health Organization:Geneva.
172. World Health Organization. 2007. Clinical management of human infection with avian influenza A (H5N1) virus. Available at http://www.who.int/csr/disease_avian_influenza/guidelines/ClinicalManage ment07.pdf.
173. World Health Organization. 2007. Avian influenza, including influenza A (H5N1) in humans:World Health Organization interim infection control guideline for health care facilities. Available at http://www.who.int/csr/disease/avian_ influenza/guidelines/infectioncontrol1/en/. World Health Organization:Geneva.
174. World Health Organization. 2007. WHA58.3 Revision of the international health regulations. Available at http://www.who.int/gb/ebwha/pdf_files/WHA58/WHA58_3-en.pdf. World Health Organization:Geneva.
175. World Health Organization. 2006. World Health Organization case definitions for human infections with influenza A(H5N1) virus. Available at http://www.who.int/csr/disease/avian_influenza/guidelines/case_definitio n2006_08_29/en/. World Health Organization:Geneva.
176. World Health Organization. 2006. World Health Organization reference laboratories for diagnosis of influenza A/H5 infection. Available at http://www.who.int/csr/disease/avian_influenza/guidelines/referencelabs/ en/. World Health Organization:Geneva.
177. World Health Organization. 2006. Collecting, preserving and shipping specimens for the diagnosis of avian influenza A(H5N1) virus infection guide for field operations. Available at http://www.who.int/entity/csr/resources/publications/surveillance/World Health Organization_CDS_EPR_ARO_2006_1/en/index.html. World Health Organization:Geneva.
178. World Health Organization. 2007. Update:World Health Organization-confirmed human cases of avian influenza A(H5N1) infection, 25 November 2003-24 November 2006. Weekly Epidemiological Record 82:41-47.
179. World Health Organization. 2007. World Health Organization guidelines for investigation of human cases of avian influenza A(H5N1). Available at http://www.who.int/entity/csr/resources/publications/influenza/World Health Organization_CDS_EPR_GIP_2006_4/en/index.html. World Health Organization:Genva.
180. Wright, P.F., and R.G. Webster. 2001. Orthomyxoviruses. In:D.M. Knipe, P.M. Howley, D.E. Griffin, R.A. Lamb, M.A. Martin, B. Roizman, S.E. Straus (eds.). Fields Virology, 4th ed. Lippincott:Philadelphia, PA, pp. 1533-1579.
181. Yeldandi, A.V., and T.V. Colby. 1994. Pathologic features of lung biopsy specimens from influenza pneumonia cases. Human Pathology 25(1):47-53.
182. Yingst, S.L., M.D. Saad, and S.A. Felt. 2006. Qinghai-like H5N1 from domestic cats, northern Iraq. Emerging Infectious Diseases 12(8):1295-1297.
183. Yu, H.E.A. 2007. Human influenza A (H5N1) cases, urban areas of People's Republic of China, 2005-2006. Emerging Infectious Diseases 13:1061-1064.
184. Yuanji, G. 2002. Influenza activity in China:1998-1999. Vaccine 20(Suppl. 2):S28-S35.
185. Zhou, B., Zhong N., and Y. Guan. 2007. Treatment with convalescent plasma for influenza A (H5N1) infection. New England Journal of Medicine. 357:1450-1451.
186. Zhu, Q.Y., E.D. Qin, W. Wang, J. Yu, B.H. Liu, Y. Hu, J.F. Hu, and W.C. Cao. 2006. Fatal infection with influenza A (H5N1) virus in China. New England Journal of Medicine 354(25):2731-2732.
187. Ziegler, T., H. Hall, A. Sanchez-Fauquier, W.C. Gamble, and N.J. Cox. 1995. Type-and subtypespecific detection of influenza viruses in clinical specimens by rapid culture assay. Journal of Clinical Microbiology 33(2):318-321.